International Psychogeriatrics · 2000 · 10 citations · 4 references
MedicinePharmacologyPsychologyDementiaGeriatric PsychiatryPsychopharmacologyAlzheimer DiseaseBehavioral SymptomsCognitive ImpairmentDementia CareDementia SyndromesDementia TreatmentBehavioral Management In DementiaDementia DifferentiationDementia-related Behavioral Symptom ManagementNeuropsychiatric Symptoms Of DementiaPharmacological Treatment Of DementiaPsychological Symptom ManagementRating Scale AnalysisResponsiveness
The Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD) was specifically designed to assess behavioral and psychological symptoms of dementia (BPSD) that would be remediable to both psychologic and pharmacologic intervention. Furthermore, the BEHAVE-AD was designed to assess categories of symptoms that would respond in a cohesive (syndrome) manner in dementia patients, independently of effects of interventions on cognition and functioning. Current data indicate that the BEHAVE-AD does indeed assess a cohesive, cognition- and function independent syndrome in AD and in related dementias that is responsive to psychologic and appropriate pharmacologic intervention. Evidence is also increasing for differential responsiveness of this BPSD syndrome to select pharmacologic agents compared with nonspecific psychologic (placebo) intervention. This article reviews the evidence for this BPSD syndrome in dementia patients, as assessed with the BEHAVE-AD.
4
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Barry Reisberg, Steven H. Ferris, Carol Torossian et al. · International Psychogeriatrics · 1992 · 42 citations · Full text